Search clinical trials for: BMS-986253
Total 3142 results
-
Matthew DallosBristol-Myers SquibbTerminatedSolid Tumor | Sars-CoV2 | Hematological MalignancyUnited States
-
Bristol-Myers SquibbCompletedLupus Erythematosus, CutaneousGermany
-
Bristol-Myers SquibbCompletedPulmonary FibrosisCanada, France, United States, Argentina, Australia, Belgium, Brazil, Chile, China, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Spain, Taiwan, United Kingdom
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
Bristol-Myers SquibbTerminatedRheumatoid Arthritis | Inflammatory Bowel Diseases | Psoriasis | Nonalcoholic Steatohepatitis | Ankylosing SpondylitisNetherlands
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbTerminatedHealthy Participants | Primary Sjögren's SyndromeGermany, United States
-
Bristol-Myers SquibbRecruitingSystemic Lupus ErythematosusUnited States, Taiwan, Japan, Brazil, Colombia, Germany, Poland, Puerto Rico, China, Mexico, Argentina, France, Chile, Australia, India, Spain, United Kingdom, Romania, Ireland
-
Bristol-Myers SquibbCompletedHeart FailureUnited States
-
Bristol-Myers SquibbRecruitingProgressive Pulmonary FibrosisChina, United States, Japan, Korea, Republic of, Taiwan, Hungary, Canada, Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Mexico, Netherlands, Peru, Polan... and more
-
Bristol-Myers SquibbRecruitingIdiopathic Pulmonary FibrosisChina, Taiwan, United States, Australia, Japan, Korea, Republic of, United Kingdom, Canada, Israel, Argentina, Austria, Belgium, Brazil, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, India, Ireland, Italy, ... and more
-
Bristol-Myers SquibbCompletedHeart Decompensation, AcuteUnited States
-
Bristol-Myers SquibbCompletedAcute Decompensated Heart FailureUnited Kingdom, Israel, Argentina, Czechia, Greece, Poland
-
Bristol-Myers SquibbCompletedMediators of InflammationUnited States
-
Bristol-Myers SquibbCompletedLiver Fibrosis | Hepatic CirrhosisUnited States
-
Bristol-Myers SquibbThis trial was conducted previously by CormorantCompleted
-
Bristol-Myers SquibbCompletedHeart Decompensation, AcuteUnited States
-
Bristol-Myers SquibbCompletedCardiac Failure | Myocardial FailureUnited States
-
Bristol-Myers SquibbCompletedRenal Failure | Congestive Heart Failure | Kidney Failure | Cardiac Failure | Myocardial FailurePoland, Czechia
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbRecruitingHealthy ParticipantsUnited Kingdom
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited Kingdom, Netherlands
-
Bristol-Myers SquibbTerminatedHeart FailureSpain, United Kingdom, Netherlands, Czechia, Poland
-
Bristol-Myers SquibbRecruitingMelanomaSpain, United States, Italy, Chile, Greece, Argentina
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Dana-Farber Cancer InstituteStand Up To CancerActive, not recruitingLymphoma | Solid Tumor, Childhood | Brain Tumor, PediatricUnited States, Canada
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited Kingdom, Netherlands
-
Edward KimBristol-Myers Squibb; National Cancer Institute (NCI)TerminatedUnresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IVB Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma... and other conditionsUnited States
-
Bristol-Myers SquibbActive, not recruiting
-
Bristol-Myers SquibbCompletedHeart FailureFrance, Germany, Japan, Spain, United States, Argentina, Poland, Italy, Czechia, Greece, Netherlands, Canada, United Kingdom
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedGastric Cancer | Esophageal Cancer | Gastric Adenocarcinoma | Esophagogastric Cancer | Gastroesophageal Junction Adenocarcinoma | Esophagus Cancer | Gastroesophageal Junction Squamous Cell CarcinomaUnited States
-
Bristol-Myers SquibbCompleted
-
CelgeneActive, not recruitingEosinophilic GastroenteritisJapan
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
Bristol-Myers SquibbCompletedHealthy ParticipantsChina
-
CelgeneRecruitingEosinophilic EsophagitisUnited States
-
Bristol-Myers SquibbCompletedCongestive Heart Failure | Liver Dysfunction | Heart Decompensation | Cardiac Failure | Liver Insufficiency | Myocardial Failure | Hepatic FailureHungary, Poland
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Carcinoma in the Liver | Metastatic Carcinoma in the Lung | Metastatic Malignant Neoplasm in the Thoracic CavityUnited States
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Imperial College Healthcare NHS TrustImperial College London; University of Oxford; Oxford University Hospitals NHS...WithdrawnLymphoma | Leukemia | Immune Thrombocytopenia | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | Myeloma | Thrombotic Thrombocytopenic Purpura (TTP)United Kingdom
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
Bristol-Myers SquibbNitto Denko CorporationCompletedModerate to Extensive Hepatic Fibrosis (METAVIR F3-4)Bulgaria, United States
-
CelgeneRecruitingEosinophilic EsophagitisUnited States, Belgium, Australia, Canada, Italy, Austria, Germany, Israel, Japan, Poland, Portugal, Spain, United Kingdom, Argentina, Switzerland